Latest Shareholder Support News

Magnum Mining and Exploration has initiated a $2.2 million entitlement offer at a significant discount, aiming to strengthen its capital base and fund key projects in Australia and the US.

Tasmea Limited has declared a fully franked special dividend of 12 cents per share, reflecting robust financial performance and strong confidence in future growth prospects.

Bio-Gene Technology Limited has raised $338,500 through a Share Purchase Plan, contributing to a total capital raise of $2.45 million to advance its bio-insecticide products.

Sultan Resources Ltd has announced a non-renounceable entitlement offer to raise up to $1.15 million, aiming to fund exploration and working capital across its diverse mineral projects.

Mount Hope Mining Limited has announced a non-renounceable pro-rata Loyalty Option Offer to raise approximately $103,125, aiming to bolster exploration funding and reward shareholder loyalty.

Cardiex Limited has raised $2.4 million through an institutional placement and launched a fully underwritten entitlement offer to raise up to $4.1 million, aiming to scale its CONNEQT Pulse device.

Podium Minerals launches a $2.61 million rights issue to advance its Parks Reef PGM project, capitalising on strong market fundamentals and significant resource growth potential.

MAC Copper Limited has entered a binding agreement for acquisition by Harmony Gold, offering shareholders a compelling 32% premium and signalling a major consolidation in the copper mining sector.

Otto Energy Limited has announced a special unfranked dividend of AUD 0.00143 per ordinary share, with key dates set for late May and mid-June 2025.

Terramin Australia’s subsidiary has nearly doubled its unsecured loan facility with major shareholder Asipac Group and extended loan terms to mid-2026, underpinning its corporate strategy amid ongoing financing plans.

GQG Partners reported robust financial results for 2024 with significant growth in funds under management and earnings, underscoring its adaptability and alignment with shareholders. The 2025 Annual Meeting confirmed strong investor confidence with near-unanimous director re-election.

IMEXHS Limited reported robust FY24 growth and launched its AI-enabled medical imaging platform Aquila+, setting the stage for expected profitability and accelerated revenue in 2025.